"Patenterprise" — Jean Luc Picard, Apple, and Androids
In space, nobody can hear you litigate.
In space, nobody can hear you litigate.
The open nature of email addresses on journal sites may be feeding the email harvesting machine for academic emails. Worse, it may also be exposing these for potentially fraudulent activity.
Books and book chapters have a competitive disadvantage in citations, but it’s not accessibility that makes the difference — there are more reasons, and more changes needed.
A new high-speed camera has the potential to reveal the world of light in completely novel ways. This video is amazing from start to finish.
Facebook’s IPO has disappointed many, but to think that it presages a complete meltdown of the online ad market is a bit of an overstatement.
What once appeared to be a lopsided ruling has, in its final form, turned into something much more definitive.
The “listener support” model works in some cases. This fact alone suggests it may not have a robust future in the funding of scholarly initiatives.
When we hear “disruption” invoked, we think it’s about technology and innovation. What if there are other types of disruption? What if there isn’t a market demanding change, but others demanding disruption?
Representing data graphically is always tricky. It doesn’t help when a journalist misses many opportunities to verify the data, provide context, and ask some probing questions.
Vitriol may have obscured important points in a post last week. The growing business strategy of our era is to drive the cost of everyone else’s product to zero in order to make more money from your own product. This imbalance stifles innovation and creation.
An interview with Fred Dylla of the American Institute of Physics, and why funding is at the heart of many issues we currently face.
The University of Missouri saga has many lessons for publishers of all types. But perhaps the harshest lesson is that we’re in a tough business.
The EU follows in lockstep with the UK, with a statement instead of a mandate. Are the gloves about to come off?
A lurid story of intramural hijinks at the FDA shows how far from mission an organization can drift when it gets its priorities wrong.
The RCUK announces its OA plans, including a six-month embargo. Now, speculation snaps into reality, and we will see if a number of lurking unintended consequences come to pass.